Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-21

Clinical Trial Results: Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia [NA]

View source ↗

Summary

Clinical trial investigating low-dose levetiracetam effects on symptoms, cognition, and hippocampal activity in schizophrenia; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Schizophrenia | NA | Status: COMPLETED | Results posted: 2026-08-21